Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998;12(6):351-5.
doi: 10.1002/(SICI)1098-2825(1998)12:6<351::AID-JCLA4>3.0.CO;2-7.

Analysis of urinary albumin, transferrin, N-acetyl-beta-D-glucosaminidase and beta2-microglobulin in patients with impaired glucose tolerance

Affiliations

Analysis of urinary albumin, transferrin, N-acetyl-beta-D-glucosaminidase and beta2-microglobulin in patients with impaired glucose tolerance

N Hiratsuka et al. J Clin Lab Anal. 1998.

Abstract

We investigated the changes in urinary albumin and urinary transferrin as glomerular proteins, and in urinary N-acetyl-beta-D-glucosaminidase and urinary beta2-microglobulin as tubular proteins, in patients with impaired glucose tolerance. We attempted to compare the proteins of normal subjects to those of diabetics with pre-nephropathy. Transferrin and N-acetyl-beta-D-glucosaminidase levels were significantly increased in patients with impaired glucose tolerance, while albumin and beta2-microglobulin levels were only slightly increased. In addition, there was no significant difference in transferrin levels between patients with impaired glucose tolerance and type 2 diabetics with pre-nephropathy. In our observation, although albumin levels were only slightly increased in patients with impaired glucose tolerance, a sharp increase in transferrin levels was reflected in patients with glomerular disorders. In addition, since N-acetyl-beta-D-glucosaminidase levels varied markedly, tubular disorders were suspected. It should be stressed that increased parameters for both glomerular and tubular disorders in group C--patients who showed abnormal levels in three proteins--had already been observed in some patients with impaired glucose tolerance. Therefore, the evaluation of the mutual relationships between various urinary protein components in patients with impaired glucose tolerance will become a more important assessment tool than that of single urinary protein components.

PubMed Disclaimer

References

    1. WHO Expert Committee on Diabetes Mellitusi Second Report. Technical Report Series, 646, 1980. - PubMed
    1. Hiratsuka N, Shiba K, Shinomura K, Hosaki S, Nishida K, Kobayashi S: Electrophoretic patterns of urinary proteins of diabetics in the pre‐, early, and overt nephropathy stages. Biol Pharm Bull 20: 651–655, 1997. - PubMed
    1. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso, M : Microalbuminuria precedes the development of NIDDM. Diabetes 43: 552–557, 1994. - PubMed
    1. Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ: Microalbuminuria in a middle‐aged workforce: Effect of hyperglycemia and ethnicity. Diabetes‐Care 16: 1485–1493, 1993. - PubMed
    1. Collins VR, Dowse GK, Plehwe WE, Imo TT, Toelupe PM, Taylor HR: High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes‐Care 18: 1140–1149, 1995. - PubMed

LinkOut - more resources